CYTK vs XRAY · rev $28.6M vs rev $1.78B
Cytokinetics Inc (CYTK) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
CYTK currently screens at market cap $4.05B. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the CYTK and XRAY stock pages for the full models.
Not investment advice.